Thinking aloud on AI, distribution, diagnostics, and what moves commercial teams from product to revenue. Written from the operator’s side of the table.
You’re probably working harder at prospecting than your results show. For a market of a few hundred labs, volume doesn’t do the math, and one wrong contact costs credibility. A different method, written down in six chapters. Free with your work email.
The choice that gets postponed for 18 months, then made under pressure
Most Nordic medtech teams agonize over direct vs. distributor for the wrong reasons. The decision is not about preference — it is about five concrete factors that determine which model can actually win. Here is how operators decide.
Why the real boundary in 2026 is between using AI and deploying it
Most AI coverage focuses on benchmarks and new model releases. The harder question — and the one that actually matters commercially — is what it takes to deploy AI as infrastructure: producing files you ship and decisions you act on, not chat transcripts you read.
Why Predictive Health Must Be for Everyone
Geoffrey Rose's 1985 prevention paradox meets home diagnostics, wearables, and AI. Why the next wave of preventive health depends on making it universally accessible — not just technically possible.